Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Atome, Adriatic,
Share Talk Weekly Stock Market News Review, Sunday 28th April 2024
The tug of war continues between the reports in the financial media, and indeed, a Goldman Sachs warning about the London stock market, and the FTSE 100 going to new
N4 Pharma PLC (AIM: N4P) Collaboration Agreement with SRI International Inc
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system designed to carry nucleotides to be developed as cancer treatments and vaccines, is delighted to
N4 Pharma PLC (AIM:N4P) Oral Delivery Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a further positive update on its
Share Talk Weekly Stock Market News Review, Sunday 18th February 2024
The FTSE 100 ended the week with a 1.5% increase. Leading the gains was NatWest, which saw its shares climb 7.09% following the confirmation of its new chief executive. Close
N4 Pharma PLC (AIM:N4P) in-vitro siRNA update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide a further encouraging update
RNS Hotlist with Zak Mir: GENF, BOOM, YCA, ROCK, VRS, AVCT, ANGS, CYK, PXEN & N4P
Genflow Bioscience (GENF) yesterday afternoon announced two research grants totally €2.9m to develop gene therapies that increase human life spans with better health.
N4 Pharma PLC (AIM:N4P) Patent Grant
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to announce that the University of Queensland has informed
RNS Hotlist with Zak Mir: THG, LIFS, BLU, NTOG, COPL, BIRD, CMRS, CABP, KIBO, BHL, EQLS, CODE, IQE, HEMO, N4P & MCB
Panmure Gordon and Liberum today announced an all-share merger to create the UK’s largest independent Investment Bank.
N4 Pharma PLC (AIM:N4P) Nanogenics Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide an update on its
N4 Pharma PLC (AIM:N4P) AAV Viral Vector Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide a further successful update
Trader’s Café With Zak Mir: The Week In Small Caps, Sunday 7th January 2024
It is difficult to look forward to 2024 without some degree of trepidation. After all, just because 2023 was exceptionally bad for most small caps, we are not necessarily due